BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1344218)

  • 61. Lectin bindings in non-neoplastic esophageal epithelium and esophageal carcinomas.
    Shirai K; Senzaki H; Uemura Y; Tsubura A
    Oncol Rep; 1996 Jan; 3(1):81-5. PubMed ID: 21594319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patterns of basement membrane deposition in benign and malignant breast tumours.
    Willebrand D; Bosman FT; de Goeij AF
    Histopathology; 1986 Dec; 10(12):1231-41. PubMed ID: 3817761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lectin-binding affinities of human breast tumors.
    Louis CJ; Sztynda T; Cheng ZM; Wyllie RG
    Cancer; 1983 Oct; 52(7):1244-50. PubMed ID: 6411323
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors.
    Franzén B; Auer G; Alaiya AA; Eriksson E; Uryu K; Hirano T; Okuzawa K; Kato H; Linder S
    Int J Cancer; 1996 Oct; 69(5):408-14. PubMed ID: 8900376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytostructural localization of peanut lectin binding in fine-needle aspirates of benign and malignant breast lesions.
    Henry MJ; Horwitz CA; Stanley MW
    Diagn Cytopathol; 1987 Dec; 3(4):310-3. PubMed ID: 3428065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lectin-binding patterns in the embryonic human paraxial mesenchyme.
    Götz W; Frisch D; Osmers R; Herken R
    Anat Embryol (Berl); 1993 Dec; 188(6):579-85. PubMed ID: 8129180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oligodendrogliomas: a clinical, histological, immunocytochemical and lectin-binding study.
    Cruz-Sanchez FF; Rossi ML; Buller JR; Carboni P; Fineron PW; Coakham HB
    Histopathology; 1991 Oct; 19(4):361-7. PubMed ID: 1937415
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TPS cytosolic levels in non-malignant breast diseases.
    Alvarez A; Martinez Rodriguez PI; Nuñez MI; Alba A; Allende MT; Ruibal Morell A
    Int J Biol Markers; 1995; 10(3):183-5. PubMed ID: 8551064
    [No Abstract]   [Full Text] [Related]  

  • 69. Lectin-binding sites in the anterior segment of the human eye.
    Rittig M; Brigel C; Lütjen-Drecoll E
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):528-32. PubMed ID: 2265767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lectin binding in retinoblastoma.
    Bardenstein DS; Rodrigues MM; Alroy J; Brownstein S
    Curr Eye Res; 1987 Sep; 6(9):1141-50. PubMed ID: 3665569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.
    Li X; Huang W; Yankeelov TE; Tudorica A; Rooney WD; Springer CS
    Magn Reson Med; 2005 Mar; 53(3):724-9. PubMed ID: 15723402
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lectin binding to normal and malignant breast tissue.
    Leathem A; Dokal I; Atkins N
    Diagn Histopathol; 1983; 6(3-4):171-80. PubMed ID: 6373198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast.
    Garde SV; Sheth AR; Joseph R; Panchal CJ; Chinoy RF; Sheth NA
    Cancer Lett; 1993 Nov; 75(1):1-9. PubMed ID: 8287377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Correlation of DBA lectin binding and malignancy in breast cancers: preliminary report].
    Osada K; Okajima K; Ryo T; Kanemoto H; Miyoshi K; Iwamoto S; Taguchi T
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1516. PubMed ID: 1287473
    [No Abstract]   [Full Text] [Related]  

  • 75. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas.
    Gabius HJ; Brehler R; Schauer A; Cramer F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):107-15. PubMed ID: 2878527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia.
    Kumar S; Mansel RE; Jasani B
    Br J Cancer; 1987 Mar; 55(3):307-9. PubMed ID: 3552018
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The detection of glucocorticoid receptors in breast cancer by immunocytochemical and biochemical methods.
    Ioannidis C; Papamichail M; Agnanti N; Garas J; Tsawdaroglou N; Sekeris CE
    Int J Cancer; 1982 Feb; 29(2):147-52. PubMed ID: 7037657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endocrine cells in a normal breast and non-cancerous breast lesion.
    Satake T; Matsuyama M
    Acta Pathol Jpn; 1991 Dec; 41(12):874-8. PubMed ID: 1785346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Rare pathology in breast neoplasms. (Juvenile papilliferous carcinoma on virile cystic mastopathy, cancerous transformation of mixed mammary tumor, sarcomatous development of fibroadenoma, phylloid intracanicular fibroadenoma)].
    BRUSCAGLI G; BAZZOCCHI R
    Arch De Vecchi Anat Patol; 1960 Feb; 30():945-82. PubMed ID: 13805403
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunohistologic c-myc protein in benign breast disease and cancer.
    Tulchin N; Ornstein L; Bleiweiss I; Dikman S; Cardiff R
    Int J Oncol; 1996 Sep; 9(3):419-25. PubMed ID: 21541529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.